I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Heerspink, H.J.
436
results:
Search for persons
X
Format
Online (436)
Mediatypes
Articles (Online) (149)
Bookchapter (Online) (4)
OpenAccess-fulltext (283)
Languages
english (383)
german (1)
more...
french (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
TIRZEPATIDE REDUCES ALBUMINURIA IN PATIENTS WITH TYPE 2 DIA..:
Heerspink, H.
;
Tuttle, K.
;
Pavo, I.
...
Canadian Journal of Diabetes. 47 (2023) 7 - p. S114 , 2023
Link:
https://doi.org/10.1016/..
?
2
TIRZEPATIDE REDUCES ALBUMINURIA IN PATIENTS WITH TYPE 2 DIA..:
Heerspink, H.
;
Tuttle, K.
;
Pavo, I.
...
Canadian Journal of Cardiology. 39 (2023) 10 - p. S144 , 2023
Link:
https://doi.org/10.1016/..
?
3
WCN23-1087 SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH ..:
Wong, M.G.
;
Heerspink, H.J.
;
Komers, R.
..
Kidney International Reports. 8 (2023) 3 - p. S126-S127 , 2023
Link:
https://doi.org/10.1016/..
?
4
IDF21-0197 Take CaRe of Me Programme: Gaps in early diagnos..:
Joshi, S.
;
Fenici, P.
;
Heerspink, H.
...
Diabetes Research and Clinical Practice. 186 (2022) - p. 109259 , 2022
Link:
https://doi.org/10.1016/..
?
5
POS-322 Association of Changes in Modifiable Factors with C..:
Nadkarni, G.
;
Takale, D.
;
Chauhan, K.
...
Kidney International Reports. 7 (2022) 2 - p. S145 , 2022
Link:
https://doi.org/10.1016/..
?
6
Effects of dapagliflozin on cardiovascular and kidney event..:
Moura, F
;
Wiviott, S
;
Chertow, G
...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
7
[18F]FDG and [18F]NaF as PET markers of systemic atheroscle..:
Reijrink, M.
;
de Boer, S.A.
;
te Velde-Keyzer, C.A.
...
Journal of Nuclear Cardiology. 29 (2022) 4 - p. 1702-1709 , 2022
Link:
https://doi.org/10.1007/..
?
8
POS-503 EVALUATING CHRONIC KIDNEY DISEASE PROGRESSION: A RE..:
ABDUL SULTAN, A.
;
Heerspink, H.
;
Arnold, M.
...
Kidney International Reports. 6 (2021) 4 - p. S218-S219 , 2021
Link:
https://doi.org/10.1016/..
?
9
PUK4 General Practitioner Utilization and Costs of Chronic ..:
Garcia Sanchez, J.J.
;
Arnold, M.
;
Carrero, J.J.
...
Value in Health. 24 (2021) - p. S234 , 2021
Link:
https://doi.org/10.1016/..
?
10
POS-319 EMERGENCY AND CRITICAL HEALTHCARE RESOURCE UTILISAT..:
GARCIA SANCHEZ, J.J.
;
Carrero, J.J.
;
Arnold, M.
...
Kidney International Reports. 6 (2021) 4 - p. S137 , 2021
Link:
https://doi.org/10.1016/..
?
11
POS-327 THE COST OF END OF LIFE INPATIENT ENCOUNTERS IN PAT..:
ARNOLD, M.
;
Garcia Sanchez, J.J.
;
Carrero, J.J.
...
Kidney International Reports. 6 (2021) 4 - p. S141 , 2021
Link:
https://doi.org/10.1016/..
?
12
POS-336 THE IMPACT OF CHRONIC KIDNEY DISEASE AND CLINICAL E..:
MCEWAN, P.
;
Darlington, O.
;
Garcia-Sanchez, J.
...
Kidney International Reports. 6 (2021) 4 - p. S146 , 2021
Link:
https://doi.org/10.1016/..
?
13
POS-223 Clinical Utility of KidneyIntelX in Patients with E..:
Lam, D.
;
Nadkarni, G.
;
Neal, B.
...
Kidney International Reports. 6 (2021) 4 - p. S93-S94 , 2021
Link:
https://doi.org/10.1016/..
?
14
Effects of canagliflozin on hyperkalaemia and serum potassi..:
Neuen, B L
;
Oshima, M
;
Perkovic, V
...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021
Link:
https://doi.org/10.1093/..
?
15
POS-335 COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS A TREATMENT ..:
MCEWAN, P.
;
Darlington, O.
;
Wheeler, D.
...
Kidney International Reports. 6 (2021) 4 - p. S145-S146 , 2021
Link:
https://doi.org/10.1016/..
1-15